NEW YORK, Nov. 15 – Large Scale Biology was issued nine new patents the company plans to use in its proteomics, functional genomics, and biomanufacturing operations, the company announced Thursday.

The patents issued to the Vacaville, Calif.-based company include US Patent No 6,254,834 for, according to the company, “distinguishing infectious agents, for identifying known viral pathogens, and for discovering and characterizing unknown viral pathogens.”